25
Participants
Start Date
November 10, 2014
Primary Completion Date
June 8, 2020
Study Completion Date
June 8, 2020
Everolimus
Induction and Dose Expansion Phase: 10 mg by mouth daily in a 28 day cycle.
LDE 225
"Induction Phase Starting Dose: 400 mg by mouth daily in a 28 day cycle.~Expansion Phase Starting Dose: Maximum tolerated dose from Induction Phase."
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Novartis
INDUSTRY
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER